LAB FY 2020 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$138M+17.8% YoY

Gross Profit

$83M60.3% margin

Operating Income

-$51M-36.9% margin

Net Income

-$53M-38.4% margin

EPS (Diluted)

$-0.74

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$28M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$325M

Total Liabilities

$186M

Stockholders' Equity

$139M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138M	$117M	+17.8%
Gross Profit	$83M	$64M	+29.6%
Operating Income	-$51M	-$52M	+1.5%
Net Income	-$53M	-$65M	+18.2%